famhp.be - FAMHP | Your medicine and health products

Example domain paragraphs

Home Human use Veterinary use Information for the public Information for professionals News Give your opinion on a genetically modified medicine for the treatment of Duchenne Muscular Dystrophy 29/03/2023 The FPS Public Health and the FAMHP invite you to participate in the public consultation on a clinical trial testing the genetically modified medicine RO7494222 (SRP-9001) for the treatment of Duchenne muscular dystrophy. The public consultation runs from 29 March to 28 April 2023. Read more about Give you

General information

Search a medicine

Links to famhp.be (12)